\uff5e ³Ô¹Ï±¬ÁÏ Site Connect\u3068³Ô¹Ï±¬ÁÏ eConsent\u306b\u3088\u308a\u3001<\/p>\n
\u30da\u30fc\u30d1\u30fc\u30ec\u30b9\u3067\u60a3\u8005\u4e2d\u5fc3\u306e\u81e8\u5e8a\u8a66\u9a13\u306b\u5411\u3051\u3066\u696d\u754c\u304c\u524d\u9032 \uff5e<\/p>\n
<\/p>\n
2020\u5e7411\u67085\u65e5<\/p>\n
³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n
³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b ³Ô¹Ï±¬ÁÏ)\u00a0\u306f\u3001³Ô¹Ï±¬ÁÏ Clinical Network\u4e0a\u3067\u521d\u3081\u3066\u69cb\u7bc9\u3055\u308c\u305f2\u7a2e\u985e\u306e\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002³Ô¹Ï±¬ÁÏ Clinical Network\u306f\u30b9\u30dd\u30f3\u30b5\u30fc\u3001\u81e8\u5e8a\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u3001\u304a\u3088\u3073\u60a3\u8005\u3092\u3064\u306a\u3044\u3067\u30da\u30fc\u30d1\u30fc\u30ec\u30b9\u3067\u60a3\u8005\u4e2d\u5fc3\u306e\u81e8\u5e8a\u8a66\u9a13\u3092\u5b9f\u73fe\u3059\u308b\u3001\u696d\u754c\u3067\u552f\u4e00\uff0a<\/sup>\u306e\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3067\u3059\u3002³Ô¹Ï±¬ÁÏ Site Connect<\/a><\/strong>\u306f\u3001\u30b9\u30dd\u30f3\u30b5\u30fc\u3068\u81e8\u5e8a\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u3092\u3064\u306a\u3044\u3067\u8a66\u9a13\u671f\u9593\u4e2d\u306e\u30da\u30fc\u30d1\u30fc\u30ec\u30b9\u306a\u60c5\u5831\u4ea4\u63db\u3092\u53ef\u80fd\u306b\u3057\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ eConsent\u306f\u3001\u6cbb\u9a13\u8cac\u4efb\u533b\u5e2b\u304c\u30b9\u30dd\u30f3\u30b5\u30fc\u306b\u5bfe\u3057\u3066\u900f\u660e\u6027\u3092\u78ba\u4fdd\u3057\u306a\u304c\u3089\u3001\u60a3\u8005\u3084\u6cbb\u9a13\u5be9\u67fb\u59d4\u54e1\u4f1a\u306e\u540c\u610f\u53d6\u5f97\u30d7\u30ed\u30bb\u30b9\u3092\u30c7\u30b8\u30bf\u30eb\u5316\u3067\u304d\u308b\u3088\u3046\u306b\u3057\u307e\u3059\u3002(\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001³Ô¹Ï±¬ÁÏ\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059\u3002\u539f\u6587\u306f\u3053\u3061\u3089<\/a><\/strong>\u304b\u3089\u304a\u8aad\u307f\u3044\u305f\u3060\u3051\u307e\u3059\u3002)<\/p>\n *\u5f53\u793e\u8abf\u3079<\/p>\n <\/p>\n ³Ô¹Ï±¬ÁÏ Vault R&D\u62c5\u5f53\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3067\u3042\u308bJim Reilly\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300c\u624b\u4f5c\u696d\u306b\u3088\u308b\u7d19\u30d9\u30fc\u30b9\u306e\u30d7\u30ed\u30bb\u30b9\u306f\u81e8\u5e8a\u8a66\u9a13\u306e\u5b9f\u65bd\u3092\u9045\u3089\u305b\u308b\u3060\u3051\u3067\u306a\u304f\u3001\u60a3\u8005\u4f53\u9a13\u306b\u3082\u5f71\u97ff\u3057\u307e\u3059\u3002\u5f53\u793e\u306f\u3001\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u306e\u9593\u3067\u62e1\u5927\u3059\u308b³Ô¹Ï±¬ÁÏ SiteVault\u30e6\u30fc\u30b6\u30fc\u30b3\u30df\u30e5\u30cb\u30c6\u30a3<\/a><\/strong>\u3068³Ô¹Ï±¬ÁÏ Vault Clinical Suite<\/a><\/strong>\u3092\u5229\u7528\u3057\u3066\u3044\u308b\u591a\u304f\u306e\u30b9\u30dd\u30f3\u30b5\u30fc\u3092\u3064\u306a\u3050\u3053\u3068\u306b\u3088\u308a\u3001\u30da\u30fc\u30d1\u30fc\u30ec\u30b9\u3067\u60a3\u8005\u4e2d\u5fc3\u306e\u81e8\u5e8a\u8a66\u9a13\u3078\u306e\u79fb\u884c\u3092\u52a0\u901f\u3055\u305b\u308b\u3053\u3068\u3092\u76ee\u6307\u3057\u3066\u3044\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ Clinical Network\u306f\u8a66\u9a13\u3092\u8fc5\u901f\u5316\u3057\u3001\u60a3\u8005\u306e\u8a66\u9a13\u53c2\u52a0\u3092\u5bb9\u6613\u306b\u3057\u307e\u3059\u3002\u300d<\/p>\n \u60c5\u5831\u5171\u6709\u3092\u81ea\u52d5\u5316\u3059\u308b<\/strong>³Ô¹Ï±¬ÁÏ Site Connect<\/strong>\u304c\u63d0\u4f9b\u958b\u59cb<\/strong><\/p>\n ³Ô¹Ï±¬ÁÏ Site Connect\u306f\u3001\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u3068\u30b9\u30dd\u30f3\u30b5\u30fc\u9593\u306e\u60c5\u5831\u5171\u6709\u3092\u624b\u4f5c\u696d\u306b\u3088\u308b\u7d19\u30d9\u30fc\u30b9\u306e\u3084\u308a\u3068\u308a\u304b\u3089\u3001\u81ea\u52d5\u5316\u3055\u308c\u305f\u30c7\u30b8\u30bf\u30eb\u4ea4\u63db\u30d7\u30ed\u30bb\u30b9\u3078\u3068\u5909\u9769\u3057\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ SiteVault\u4e0a\u3067\u306e\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u306e\u696d\u52d9\u3092Vault Clinical\u4e0a\u3067\u306e\u30b9\u30dd\u30f3\u30b5\u30fc\u306e\u696d\u52d9\u3068\u9023\u643a\u3055\u305b\u308b\u3053\u3068\u306b\u3088\u308a\u3001\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u95a2\u9023\u60c5\u5831\u306e\u4ea4\u63db\u3001\u5b89\u5168\u6027\u60c5\u5831\u306e\u914d\u5e03\u3001\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u3078\u306e\u652f\u6255\u6848\u5185\u72b6\u3001\u8a66\u9a13\u7d42\u4e86\u6642\u306e\u79fb\u8ee2\u306a\u3069\u306e\u4e3b\u8981\u306a\u81e8\u5e8a\u8a66\u9a13\u30d7\u30ed\u30bb\u30b9\u3092\u52b9\u7387\u5316\u3057\u307e\u3059\u3002\u60c5\u5831\u5171\u6709\u3092\u81ea\u52d5\u5316\u3059\u308b\u3053\u3068\u3067\u3001\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u304c\u60a3\u8005\u306e\u30b1\u30a2\u306b\u96c6\u4e2d\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308b\u3068\u540c\u6642\u306b\u3001\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u3068\u306e\u9023\u643a\u5f37\u5316\u3068\u6e80\u8db3\u5ea6\u5411\u4e0a\u306b\u3064\u306a\u304c\u308a\u307e\u3059\u3002<\/p>\n \u773c\u79d1\u306b\u7279\u5316\u3057\u305f\u88fd\u54c1\u3092\u73fe\u572860\u30ab\u56fd\u4ee5\u4e0a\u3067\u8ca9\u58f2\u3057\u3066\u3044\u308bSanten Inc.\u793e\u3067\u3001\u88fd\u54c1\u958b\u767a\u672c\u90e8\u9577\u3068\u57f7\u884c\u5f79\u54e1\u3092\u52d9\u3081\u3066\u3044\u308bPeter Sallstig\u6c0f\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300c\u81e8\u5e8a\u8a66\u9a13\u60c5\u5831\u306e\u624b\u4f5c\u696d\u306b\u3088\u308b\u7dad\u6301\u7ba1\u7406\u3084\u91cd\u8981\u306a\u8a66\u9a13\u6587\u66f8\u3078\u306e\u53ef\u8996\u6027\u306e\u5236\u9650\u306f\u3001\u30b9\u30dd\u30f3\u30b5\u30fc\u3068\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u306e\u9593\u3067\u4f5c\u696d\u306e\u91cd\u8907\u3092\u591a\u767a\u3055\u305b\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ Site Connect\u306e\u5c0e\u5165\u306b\u3088\u308a\u3001³Ô¹Ï±¬ÁÏ Vault eTMF<\/a><\/strong>\u3068³Ô¹Ï±¬ÁÏ SiteVault<\/a><\/strong>\u306e\u9593\u3067\u30b3\u30f3\u30c6\u30f3\u30c4\u304c\u81ea\u52d5\u7684\u306b\u30ea\u30f3\u30af\u3055\u308c\u305f\u3053\u3068\u3067\u3001\u30ea\u30a2\u30eb\u30bf\u30a4\u30e0\u306b\u6587\u66f8\u3092\u7ba1\u7406\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u3001\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u304c\u52b9\u7387\u5316\u3055\u308c\u3001\u8a66\u9a13\u5b9f\u65bd\u304c\u6539\u5584\u3055\u308c\u307e\u3057\u305f\u3002\u300d<\/p>\n ³Ô¹Ï±¬ÁÏ Site Connect\u306f\u63d0\u4f9b\u958b\u59cb\u3055\u308c\u3066\u304a\u308a\u3001\u4e0a\u4f4d20\u4f4d\u306b\u5165\u308b\u5927\u624b\u88fd\u85ac\u4f01\u696d\u3001\u4e0a\u4f4d10\u4f4d\u306b\u5165\u308b\u533b\u7642\u6a5f\u5668\u30e1\u30fc\u30ab\u30fc\u3001\u696d\u754c\u3092\u727d\u5f15\u3059\u308b\u81e8\u5e8a\u7814\u7a76\u75c5\u9662\u304c\u3001\u30a2\u30fc\u30ea\u30fc\u30a2\u30c0\u30d7\u30bf\u30fc\u3068\u3057\u3066\u65e2\u306b\u4f7f\u7528\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n \u60a3\u8005\u306e\u81e8\u5e8a\u8a66\u9a13\u3078\u306e\u53c2\u52a0\u3092\u5bb9\u6613\u306b\u3059\u308b<\/strong>³Ô¹Ï±¬ÁÏ eConsent<\/strong><\/p>\n ³Ô¹Ï±¬ÁÏ eConsent\u306f\u3001\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u304a\u3088\u3073\u60a3\u8005\u5411\u3051\u306e\u7121\u6599\u306e\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3067\u3001\u5f93\u6765\u306e\u7d19\u30d9\u30fc\u30b9\u306e\u540c\u610f\u53d6\u5f97\u30d7\u30ed\u30bb\u30b9\u3092\u30c7\u30b8\u30bf\u30eb\u4f5c\u6210\u30fb\u627f\u8a8d\u30fb\u4ea4\u63db\u30d7\u30ed\u30bb\u30b9\u3078\u3068\u5909\u9769\u3057\u307e\u3059\u3002\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u306f\u3001³Ô¹Ï±¬ÁÏ eConsent\u3092\u4f7f\u7528\u3057\u3066\u3001\u30b9\u30dd\u30f3\u30b5\u30fc\u304c\u7528\u610f\u3057\u305f\u540c\u610f\u66f8\u3092\u81ea\u9662\u306e\u502b\u7406\u59d4\u54e1\u4f1a\u306e\u8981\u4ef6\u306b\u5408\u308f\u305b\u3066\u8abf\u6574\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002\u627f\u8a8d\u3055\u308c\u305f\u540c\u610f\u66f8\u306f\u305d\u306e\u5f8c\u3001\u540c\u610f\u53d6\u5f97\u306e\u305f\u3081\u306b\u60a3\u8005\u306e\u30e2\u30d0\u30a4\u30eb\u30c7\u30d0\u30a4\u30b9\u306b\u9001\u4fe1\u3055\u308c\u3001\u305d\u306e\u30d7\u30ed\u30bb\u30b9\u5168\u4f53\u304c\u53ef\u8996\u5316\u3055\u308c\u308b\u305f\u3081\u3001\u30b9\u30dd\u30f3\u30b5\u30fc\u306f\u72b6\u6cc1\u3092\u628a\u63e1\u3067\u304d\u307e\u3059\u3002<\/p>\n Vanderbilt University Medical Center\u306e\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u3067\u3042\u308bJill Janssen\u6c0f\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300c\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3051\u308b\u60c5\u5831\u306b\u57fa\u3065\u304f\u540c\u610f\u53d6\u5f97\u30d7\u30ed\u30bb\u30b9\u306f\u3001\u6b74\u53f2\u7684\u306b\u7d19\u30d9\u30fc\u30b9\u3067\u975e\u52b9\u7387\u3067\u3057\u305f\u3002³Ô¹Ï±¬ÁÏ eConsent\u306f\u8907\u96d1\u3067\u6642\u9593\u306e\u304b\u304b\u308b\u66f8\u985e\u696d\u52d9\u3092\u524a\u6e1b\u3057\u3001\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3092\u6539\u5584\u3059\u308b\u3068\u5171\u306b\u60a3\u8005\u4f53\u9a13\u3092\u5411\u4e0a\u3055\u305b\u3066\u304f\u308c\u307e\u3059\u3002\u300d<\/p>\n ³Ô¹Ï±¬ÁÏ eConsent\u306f\u30012021\u5e74\u524d\u534a\u306b\u63d0\u4f9b\u958b\u59cb\u3092\u4e88\u5b9a\u3057\u3066\u3044\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ eConsent\u304a\u3088\u3073³Ô¹Ï±¬ÁÏ Site Connect\u306b\u3064\u3044\u3066\u306f\u30012020\u5e7410\u670813\uff5e14\u65e5\u306b\u958b\u50ac\u3055\u308c\u3001\u5f15\u304d\u7d9a\u304d\u30aa\u30f3\u30c7\u30de\u30f3\u30c9\u914d\u4fe1\u4e2d\u306e³Ô¹Ï±¬ÁÏ R&D and Quality Summit<\/a><\/strong>\u3067\u3082\u8a73\u3057\u304f\u53d6\u308a\u4e0a\u3052\u3089\u308c\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u30aa\u30f3\u30e9\u30a4\u30f3\u30a4\u30d9\u30f3\u30c8\u306f\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u95a2\u4fc2\u8005\u9650\u5b9a\u306e\u30a4\u30d9\u30f3\u30c8\u3067\u3059\u3002\u3054\u8996\u8074\u767b\u9332\u304a\u3088\u3073\u6700\u65b0\u60c5\u5831\u306b\u3064\u3044\u3066\u306fveeva.com\/R&D\/Summit<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n <\/p>\n \u3010<\/strong>³Ô¹Ï±¬ÁÏ Systems<\/strong>\u793e\u306b\u3064\u3044\u3066\u3011<\/strong> \u3010Forward-looking Statements\u3011 ³Ô¹Ï±¬ÁÏ Clinical Network\u306f\u30b9\u30dd\u30f3\u30b5\u30fc\u3001\u81e8\u5e8a\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u3001\u304a\u3088\u3073\u60a3\u8005\u3092\u3064\u306a\u3044\u3067\u30da\u30fc\u30d1\u30fc\u30ec\u30b9\u3067\u60a3\u8005\u4e2d\u5fc3\u306e\u81e8\u5e8a\u8a66\u9a13\u3092\u5b9f\u73fe\u3059\u308b\u3001\u696d\u754c\u3067\u552f\u4e00\u306e\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3067\u3059\u3002<\/p>\n","protected":false},"author":131,"featured_media":44194,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322,341],"tags":[],"class_list":["post-44192","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-release","category-case-study"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/44192"}],"collection":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=44192"}],"version-history":[{"count":3,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/44192\/revisions"}],"predecessor-version":[{"id":44198,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/44192\/revisions\/44198"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/media\/44194"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=44192"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=44192"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=44192"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n³Ô¹Ï±¬ÁÏ Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u5411\u3051\u306b\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067\u3001900\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u306b\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u306b\u30b3\u30df\u30c3\u30c8\u3059\u308b\u69d8\u3005\u306a\u30b5\u30fc\u30d3\u30b9\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ\u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55\u958b\u3057\u3066\u3044\u307e\u3059\u3002
\n\u8a73\u3057\u304f\u306f\u3001https:\/\/veeva.com\/jp\/<\/a>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n
\nThis release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ\u2019s products and services, the results from use of ³Ô¹Ï±¬ÁÏ\u2019s products and services, and general business conditions (including the on-going impact of COVID-19), particularly within the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-Q for the period ended July 31, 2020. This is available on the company\u2019s website at veeva.com under the Investors section and on the SEC\u2019s website at sec.gov. Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"